Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr
Read the original post:
Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache


Comments
Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!